Review article · 2025 · Open access
Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group
Cytotherapy, 27(9), 1031–1042 · Published 8 April 2025 · DOI 10.1016/j.jcyt.2025.04.058
In brief
“Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group” is a 2025 review article by Natalie Francis and 11 co-authors, published in Cytotherapy. OpenAlex counts 23 citations as of 21 November 2026, which puts it in the top 5% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Cytotherapy.
- Citations
- 23
- Most cited in
- 2026 (20)
- Field-weighted impact
- 1.48
- References
- 94
- Authors
- 12
Abstract
Approval of induced pluripotent stem cells (iPSCs) for the manufacture of cell therapies to support clinical trials is now becoming realized after more than 20 years of research and development. However, manufacturing these therapies at the scale required for patient treatment, as well as for key clinical trial enabling activities such as preclinical and stability studies, remains a challenge. In 2022 the International Society for Cell and Gene Therapy (ISCT) established a Working Group on Emerging Regenerative Medicine Technologies, an area in which iPSC-derived technologies are expected to play a key role. In this article, the Working Group provides an overview of the considerations and challenges facing stem cell therapy developers, including development-stage specific manufacturing processes, the decision on when to implement automation, the choice of technology and different requirements of expansion and differentiation aspects of the process, and the integration of automation for both manufacturing and analytics in an end-to-end manufacturing process. The role of scalable manufacturing technologies in the application of quality-by-design approaches to product development, and the use of design-of-experiment approaches for increased product characterization, is discussed. Finally, we provide an in-depth review of the different technologies that have been used for expansion and differentiation of iPSC-derived therapies to date, including compatibility with good manufacturing practice requirements and process analytical technologies. We hope that this overview will summarize the existing knowledge in the field and reduce the challenges that therapy developers face in translating their research into clinical and commercial scale manufacturing.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Francis, N., Aho, J., Ben‐Nun, I. F., Bharti, K., Dianat, N., Makovoz, B., Nouri, P., Rothberg, J., Song, H. W., Zamilpa, R., Lakshmipathy, U., & Allickson, J. G. (2025). Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group. Cytotherapy, 27(9), 1031–1042. https://doi.org/10.1016/j.jcyt.2025.04.058
MLA 9
Francis, Natalie, et al. “Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group.” Cytotherapy, vol. 27, no. 9, 2025, pp. 1031–1042. https://doi.org/10.1016/j.jcyt.2025.04.058.
Chicago
Francis, Natalie, Joy Aho, Inbar Friedrich Ben‐Nun, Kapil Bharti, Noushin Dianat, Bar Makovoz, Parivash Nouri, et al. 2025. “Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group.” Cytotherapy 27 (9): 1031–1042. https://doi.org/10.1016/j.jcyt.2025.04.058.
Harvard
Francis, N. et al. (2025) ‘Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group’, Cytotherapy, 27(9), pp. 1031–1042. doi:10.1016/j.jcyt.2025.04.058.
IEEE
N. Francis et al., “Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group,” Cytotherapy, vol. 27, no. 9, pp. 1031–1042, 2025, doi: 10.1016/j.jcyt.2025.04.058.
BibTeX
@article{francis2025scaling,
title = {{Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group}},
author = {Francis, Natalie and Aho, Joy and Ben‐Nun, Inbar Friedrich and Bharti, Kapil and Dianat, Noushin and Makovoz, Bar and Nouri, Parivash and Rothberg, Janet and Song, Hannah W. and Zamilpa, Rogelio and Lakshmipathy, Uma and Allickson, Julie G.},
journal = {Cytotherapy},
year = {2025},
volume = {27},
number = {9},
pages = {1031--1042},
doi = {10.1016/j.jcyt.2025.04.058},
url = {https://doi.org/10.1016/j.jcyt.2025.04.058}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- induced pluripotent stem cells
- cell therapy manufacturing
- scale-up
- automation
- quality by design
- experimental design
- process analytical technology
- iPSC differentiation
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Francis, N., Aho, J., Ben‐Nun, I. F., Bharti, K., Dianat, N., Makovoz, B., Nouri, P., Rothberg, J., Song, H. W., Zamilpa, R., Lakshmipathy, U., & Allickson, J. G. (2025). Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group. Cytotherapy, 27(9), 1031–1042. https://doi.org/10.1016/j.jcyt.2025.04.058
How many times has this paper been cited?
23 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cytotherapy: sign in and open the PDF from this page.
Who wrote this paper?
Natalie Francis, Joy Aho, Inbar Friedrich Ben‐Nun, Kapil Bharti, Noushin Dianat, Bar Makovoz, Parivash Nouri, Janet Rothberg, Hannah W. Song, Rogelio Zamilpa, Uma Lakshmipathy, Julie G. Allickson.
What is the DOI of this paper?
10.1016/j.jcyt.2025.04.058, permanently at https://doi.org/10.1016/j.jcyt.2025.04.058. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.